The successful replacement of small-diameter blood vessels, affected by cardiovascular disease, with natural and synthetic bypass grafts remains limited due to long-term patency issues. The development of a small-diameter tissue engineered blood vessel (TEBV), with equivalent biomechanical properties to the vessel being replaced, may provide a potential solution. This thesis aims to determine the biomechanical properties of porcine coronary arteries (PCA) and the corresponding natural matrix scaffold of the artery through short-term decellularisation providing vital information for the development of an optimum TEBV, while also establishing the potential of this natural matrix scaffold to be used as a vascular tissue engineering scaffold. ...
Each year as cardiovascular disease continues to be one of the leading causes of death world wide, n...
Cardiovascular diseases are the leading cause of death worldwide. Blood vessel replacement is a comm...
Compliance mismatch is a significant hurdle to long-term patency in small-diameter arterial bypass g...
The successful replacement of small-diameter blood vessels, affected by cardiovascular disease, with...
The patency rate of small diameter synthetic bypass grafts remains poor. The aim of this study was t...
Every 34 seconds, someone in the United States suffers from a heart attack. Most heart attacks are ...
Laboratory of Tissue Engineering and Cells Culture, Nicolae Testemitanu State University of Medicine...
Several challenges persist when attempting to utilize decellularized tissue as a scaffold for vascul...
Cardiovascular system is composed of the heart, blood vessels and blood. This system consists of fiv...
Coronary artery disease is one of the number one killers in the U.S. Current treatment of using CABG...
Suggesting that bioartificial vascular scaffolds cannot but tissue-engineered vessels can withstand ...
The Cardiovascular diseases (CVDs) continue to be the leading cause of morbidity and mortality world...
Alternatives to using native arteries in vascular surgery are urgently needed. Vessels made from syn...
There are two main surgical treatments for vascular diseases, (i) percutaneous stent deployment and...
Cardiovascular Disease is the number one cause of death in the world, with a mortality rate, globall...
Each year as cardiovascular disease continues to be one of the leading causes of death world wide, n...
Cardiovascular diseases are the leading cause of death worldwide. Blood vessel replacement is a comm...
Compliance mismatch is a significant hurdle to long-term patency in small-diameter arterial bypass g...
The successful replacement of small-diameter blood vessels, affected by cardiovascular disease, with...
The patency rate of small diameter synthetic bypass grafts remains poor. The aim of this study was t...
Every 34 seconds, someone in the United States suffers from a heart attack. Most heart attacks are ...
Laboratory of Tissue Engineering and Cells Culture, Nicolae Testemitanu State University of Medicine...
Several challenges persist when attempting to utilize decellularized tissue as a scaffold for vascul...
Cardiovascular system is composed of the heart, blood vessels and blood. This system consists of fiv...
Coronary artery disease is one of the number one killers in the U.S. Current treatment of using CABG...
Suggesting that bioartificial vascular scaffolds cannot but tissue-engineered vessels can withstand ...
The Cardiovascular diseases (CVDs) continue to be the leading cause of morbidity and mortality world...
Alternatives to using native arteries in vascular surgery are urgently needed. Vessels made from syn...
There are two main surgical treatments for vascular diseases, (i) percutaneous stent deployment and...
Cardiovascular Disease is the number one cause of death in the world, with a mortality rate, globall...
Each year as cardiovascular disease continues to be one of the leading causes of death world wide, n...
Cardiovascular diseases are the leading cause of death worldwide. Blood vessel replacement is a comm...
Compliance mismatch is a significant hurdle to long-term patency in small-diameter arterial bypass g...